These results suggest that glucose uptake may be differently modulated in HCC cells, possibly involving glucose transporters other than GLUT-1 as well as HIF-1α-independent mechanisms that are not affected by palbociclib. This evidence concerns the gene HIF1A and hepatocellular carcinoma.